BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24556213)

  • 1. A mutation in PAK3 with a dual molecular effect deregulates the RAS/MAPK pathway and drives an X-linked syndromic phenotype.
    Magini P; Pippucci T; Tsai IC; Coppola S; Stellacci E; Bartoletti-Stella A; Turchetti D; Graziano C; Cenacchi G; Neri I; Cordelli DM; Marchiani V; Bergamaschi R; Gasparre G; Neri G; Mazzanti L; Patrizi A; Franzoni E; Romeo G; Bordo D; Tartaglia M; Katsanis N; Seri M
    Hum Mol Genet; 2014 Jul; 23(13):3607-17. PubMed ID: 24556213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAK3 mutations responsible for severe intellectual disability and callosal agenesis inhibit cell migration.
    Duarte K; Heide S; Poëa-Guyon S; Rousseau V; Depienne C; Rastetter A; Nava C; Attié-Bitach T; Razavi F; Martinovic J; Moutard ML; Cherfils J; Mignot C; Héron D; Barnier JV
    Neurobiol Dis; 2020 Mar; 136():104709. PubMed ID: 31843706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A de novo mutation in the X-linked PAK3 gene is the underlying cause of intellectual disability and macrocephaly in monozygotic twins.
    Hertecant J; Komara M; Nagi A; Al-Zaabi O; Fathallah W; Cui H; Yang Y; Eng CM; Al Sorkhy M; Ghattas MA; Al-Gazali L; Ali BR
    Eur J Med Genet; 2017 Apr; 60(4):212-216. PubMed ID: 28126652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel
    Iida A; Takano K; Takeshita E; Abe-Hatano C; Hirabayashi S; Inaba Y; Kosugi S; Kamatani Y; Momozawa Y; Kubo M; Nakagawa E; Inoue K; Goto YI
    Cold Spring Harb Mol Case Stud; 2019 Dec; 5(6):. PubMed ID: 31444167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Molecular Aspects of the Neurodevelopmental Disorder Associated with PAK3 Perturbation.
    Pascolini G; Gaudioso F; Passarelli C; Novelli A; Di Giosaffatte N; Majore S; Grammatico P
    J Mol Neurosci; 2021 Dec; 71(12):2474-2481. PubMed ID: 34227036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p21-activated kinase PAK3 forms heterodimers with PAK1 in brain implementing trans-regulation of PAK3 activity.
    Combeau G; Kreis P; Domenichini F; Amar M; Fossier P; Rousseau V; Barnier JV
    J Biol Chem; 2012 Aug; 287(36):30084-96. PubMed ID: 22815483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of rare variants found in schizophrenia implicates a critical role for GIT1-PAK3 signaling in neuroplasticity.
    Kim MJ; Biag J; Fass DM; Lewis MC; Zhang Q; Fleishman M; Gangwar SP; Machius M; Fromer M; Purcell SM; McCarroll SA; Rudenko G; Premont RT; Scolnick EM; Haggarty SJ
    Mol Psychiatry; 2017 Mar; 22(3):417-429. PubMed ID: 27457813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-Activated Kinase 3 (PAK3)-Related Intellectual Disability Associated with Combined Immunodeficiency: A Case Report.
    Almutairi O; Almutairi HA; Al Rushood M
    Am J Case Rep; 2021 May; 22():e930966. PubMed ID: 34014906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation.
    Bienvenu T; des Portes V; McDonell N; Carrié A; Zemni R; Couvert P; Ropers HH; Moraine C; van Bokhoven H; Fryns JP; Allen K; Walsh CA; Boué J; Kahn A; Chelly J; Beldjord C
    Am J Med Genet; 2000 Aug; 93(4):294-8. PubMed ID: 10946356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The four mammalian splice variants encoded by the p21-activated kinase 3 gene have different biological properties.
    Kreis P; Rousseau V; Thévenot E; Combeau G; Barnier JV
    J Neurochem; 2008 Aug; 106(3):1184-97. PubMed ID: 18507705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel splice mutation in PAK3 gene underlying mental retardation with neuropsychiatric features.
    Rejeb I; Saillour Y; Castelnau L; Julien C; Bienvenu T; Taga P; Chaabouni H; Chelly J; Ben Jemaa L; Bahi-Buisson N
    Eur J Hum Genet; 2008 Nov; 16(11):1358-63. PubMed ID: 18523455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intellectual disability PAK3 R67C mutation impacts cognitive functions and adult hippocampal neurogenesis.
    Castillon C; Gonzalez L; Domenichini F; Guyon S; Da Silva K; Durand C; Lestaevel P; Vaillend C; Laroche S; Barnier JV; Poirier R
    Hum Mol Genet; 2020 Jul; 29(12):1950-1968. PubMed ID: 31943058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of synaptic network dynamics by the intellectual disability protein PAK3.
    Dubos A; Combeau G; Bernardinelli Y; Barnier JV; Hartley O; Gaertner H; Boda B; Muller D
    J Neurosci; 2012 Jan; 32(2):519-27. PubMed ID: 22238087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intellectual disability protein PAK3 regulates oligodendrocyte precursor cell differentiation.
    Maglorius Renkilaraj MRL; Baudouin L; Wells CM; Doulazmi M; Wehrlé R; Cannaya V; Bachelin C; Barnier JV; Jia Z; Nait Oumesmar B; Dusart I; Bouslama-Oueghlani L
    Neurobiol Dis; 2017 Feb; 98():137-148. PubMed ID: 27940202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated evolution of PAK3- and PIM1-like kinase gene families in the zebra finch, Taeniopygia guttata.
    Kong L; Lovell PV; Heger A; Mello CV; Ponting CP
    Mol Biol Evol; 2010 Aug; 27(8):1923-34. PubMed ID: 20237222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p21-Activated kinase 3 (PAK3) protein regulates synaptic transmission through its interaction with the Nck2/Grb4 protein adaptor.
    Thévenot E; Moreau AW; Rousseau V; Combeau G; Domenichini F; Jacquet C; Goupille O; Amar M; Kreis P; Fossier P; Barnier JV
    J Biol Chem; 2011 Nov; 286(46):40044-59. PubMed ID: 21949127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominant Noonan syndrome-causing LZTR1 mutations specifically affect the Kelch domain substrate-recognition surface and enhance RAS-MAPK signaling.
    Motta M; Fidan M; Bellacchio E; Pantaleoni F; Schneider-Heieck K; Coppola S; Borck G; Salviati L; Zenker M; Cirstea IC; Tartaglia M
    Hum Mol Genet; 2019 Mar; 28(6):1007-1022. PubMed ID: 30481304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21-Activated kinase 3 promotes cancer stem cell phenotypes through activating the Akt-GSK3β-β-catenin signaling pathway in pancreatic cancer cells.
    Wu HY; Yang MC; Ding LY; Chen CS; Chu PC
    Cancer Lett; 2019 Aug; 456():13-22. PubMed ID: 31051214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak.
    Sun H; King AJ; Diaz HB; Marshall MS
    Curr Biol; 2000 Mar; 10(5):281-4. PubMed ID: 10712905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research progress on nonsyndromic X-linked mental retardation related gene PAK3].
    Gao XC; Xi GS; Zhang FC
    Yi Chuan; 2007 May; 29(5):523-7. PubMed ID: 17548318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.